Conserved eukaryotic protein. Probable receptor for ER-Golgi trafficking of GPI-anchored proteins. Related to metazoan Tmed10.. Localization: ER (by homology) / Golgi (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 10, no: 0 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 5 | 2 |
GO:0005794 | Golgi apparatus | 5 | 2 |
GO:0016020 | membrane | 2 | 10 |
GO:0030134 | COPII-coated ER to Golgi transport vesicle | 8 | 2 |
GO:0030135 | coated vesicle | 7 | 2 |
GO:0031410 | cytoplasmic vesicle | 6 | 2 |
GO:0031982 | vesicle | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0097708 | intracellular vesicle | 5 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: Q4Q1K6
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007030 | Golgi organization | 5 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0048193 | Golgi vesicle transport | 5 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.401 |
CLV_NRD_NRD_1 | 166 | 168 | PF00675 | 0.571 |
CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.456 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 205 | 207 | PF00082 | 0.489 |
CLV_PCSK_PC1ET2_1 | 165 | 167 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 205 | 207 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.686 |
CLV_PCSK_SKI1_1 | 205 | 209 | PF00082 | 0.357 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.321 |
DEG_APCC_DBOX_1 | 190 | 198 | PF00400 | 0.370 |
DEG_MDM2_SWIB_1 | 233 | 241 | PF02201 | 0.370 |
DOC_CDC14_PxL_1 | 15 | 23 | PF14671 | 0.468 |
DOC_CYCLIN_RxL_1 | 199 | 209 | PF00134 | 0.227 |
DOC_MAPK_gen_1 | 137 | 145 | PF00069 | 0.391 |
DOC_MAPK_gen_1 | 165 | 174 | PF00069 | 0.315 |
DOC_MAPK_MEF2A_6 | 137 | 145 | PF00069 | 0.391 |
DOC_PP1_RVXF_1 | 47 | 54 | PF00149 | 0.370 |
DOC_PP1_RVXF_1 | 8 | 14 | PF00149 | 0.653 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.583 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.393 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.580 |
LIG_14-3-3_CanoR_1 | 224 | 233 | PF00244 | 0.247 |
LIG_Actin_WH2_2 | 243 | 261 | PF00022 | 0.363 |
LIG_BRCT_BRCA1_1 | 127 | 131 | PF00533 | 0.393 |
LIG_CORNRBOX | 243 | 251 | PF00104 | 0.488 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.249 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.314 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.343 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.290 |
LIG_IRF3_LxIS_1 | 211 | 218 | PF10401 | 0.227 |
LIG_LIR_Gen_1 | 230 | 241 | PF02991 | 0.312 |
LIG_LIR_Gen_1 | 42 | 51 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 230 | 236 | PF02991 | 0.321 |
LIG_LIR_Nem_3 | 42 | 46 | PF02991 | 0.355 |
LIG_NRBOX | 20 | 26 | PF00104 | 0.515 |
LIG_Pex14_2 | 233 | 237 | PF04695 | 0.356 |
LIG_SH2_SRC | 177 | 180 | PF00017 | 0.399 |
LIG_SH2_STAP1 | 97 | 101 | PF00017 | 0.393 |
LIG_SH2_STAT3 | 175 | 178 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 175 | 178 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.183 |
LIG_TRAF2_1 | 176 | 179 | PF00917 | 0.393 |
LIG_TYR_ITIM | 41 | 46 | PF00017 | 0.338 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.313 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.393 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.385 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.370 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.546 |
MOD_GlcNHglycan | 200 | 204 | PF01048 | 0.586 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.455 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.616 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.544 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.487 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.275 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.283 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.626 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.393 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.385 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.361 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.520 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.553 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.364 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.367 |
MOD_PIKK_1 | 77 | 83 | PF00454 | 0.193 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.300 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.364 |
MOD_PKB_1 | 224 | 232 | PF00069 | 0.321 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.370 |
MOD_Plk_1 | 229 | 235 | PF00069 | 0.335 |
MOD_Plk_2-3 | 173 | 179 | PF00069 | 0.290 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.393 |
MOD_SUMO_for_1 | 149 | 152 | PF00179 | 0.380 |
MOD_SUMO_rev_2 | 129 | 139 | PF00179 | 0.379 |
MOD_SUMO_rev_2 | 179 | 187 | PF00179 | 0.342 |
TRG_DiLeu_BaLyEn_6 | 17 | 22 | PF01217 | 0.523 |
TRG_DiLeu_BaLyEn_6 | 203 | 208 | PF01217 | 0.338 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.364 |
TRG_ER_diLys_1 | 264 | 268 | PF00400 | 0.624 |
TRG_NLS_MonoCore_2 | 262 | 267 | PF00514 | 0.669 |
TRG_NLS_MonoExtC_3 | 164 | 170 | PF00514 | 0.321 |
TRG_NLS_MonoExtN_4 | 263 | 268 | PF00514 | 0.684 |
TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.538 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7A9 | Leptomonas seymouri | 55% | 100% |
A0A1X0P7Z0 | Trypanosomatidae | 33% | 100% |
A0A3S7XAW3 | Leishmania donovani | 93% | 100% |
A0A422N537 | Trypanosoma rangeli | 27% | 100% |
A4HP84 | Leishmania braziliensis | 79% | 100% |
A4IDI9 | Leishmania infantum | 93% | 100% |
D0A380 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9ASZ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
P0CN72 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 26% | 100% |
P0CN73 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 26% | 100% |
V5BBT5 | Trypanosoma cruzi | 34% | 100% |